[go: up one dir, main page]

SG43036A1 - (S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid - Google Patents

(S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid

Info

Publication number
SG43036A1
SG43036A1 SG1996002715A SG1996002715A SG43036A1 SG 43036 A1 SG43036 A1 SG 43036A1 SG 1996002715 A SG1996002715 A SG 1996002715A SG 1996002715 A SG1996002715 A SG 1996002715A SG 43036 A1 SG43036 A1 SG 43036A1
Authority
SG
Singapore
Prior art keywords
methyl
aminocarbony
buthyl
cid
piperidino
Prior art date
Application number
SG1996002715A
Inventor
Wolfgang Grell
Andreas Greischel
Gabriele Zahn
Michael Mark
Hansjorg Knorr
Eckhard Rupprecht
Ulrich Muller
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36781542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG43036(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to AU80781/91A priority Critical patent/AU660930B2/en
Priority to DK91911959T priority patent/DK0589874T3/en
Priority to DE2000175006 priority patent/DE10075006I2/en
Priority to SG1996002715A priority patent/SG43036A1/en
Priority to DE59109151T priority patent/DE59109151D1/en
Priority to PCT/EP1991/001147 priority patent/WO1993000337A1/en
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Priority to RO93-01692A priority patent/RO113462B1/en
Priority to HK98112967.7A priority patent/HK1011968B/en
Priority to SK1280-93A priority patent/SK281246B6/en
Priority to EP91911959A priority patent/EP0589874B1/en
Priority to DK99101810T priority patent/DK0965591T3/en
Priority to CA002111851A priority patent/CA2111851C/en
Priority to JP3511056A priority patent/JP2921982B2/en
Priority to PL91301997A priority patent/PL170210B1/en
Priority to KR1019930703974A priority patent/KR100496720B1/en
Priority to CN91104984A priority patent/CN1048722C/en
Priority to BG98300A priority patent/BG61690B1/en
Priority to NO934726A priority patent/NO303687B1/en
Priority to FI935724A priority patent/FI106027B/en
Publication of SG43036A1 publication Critical patent/SG43036A1/en
Priority to NO1999017C priority patent/NO1999017I1/en
Priority to GR990402743T priority patent/GR3031654T3/en
Priority to UY25923A priority patent/UY25923A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG1996002715A 1991-06-21 1991-06-21 (S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid SG43036A1 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
CA002111851A CA2111851C (en) 1991-06-21 1991-06-21 (s)(+)-2-ethoxy-4-[n-{1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
EP91911959A EP0589874B1 (en) 1991-06-21 1991-06-21 Use of (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid for the preparation of a longlasting antidiabetic medicament
DE2000175006 DE10075006I2 (en) 1991-06-21 1991-06-21 Use of (S) (+) - 2-ethoxy-4- [N- [1- (2-piperidino-phenyl) -3-methyl-1-butyl [aminocarbonylmethyl] benzoic acid for the manufacture of a long-term antidiabetic.
SG1996002715A SG43036A1 (en) 1991-06-21 1991-06-21 (S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid
DE59109151T DE59109151D1 (en) 1991-06-21 1991-06-21 USE OF (S) (+) - 2-ETHOXY-4- [N- [1- (2-PIPERIDINO-PHENYL) -3-METHYL-1-BUTYL] AMINOCARBONYLMETHYL] -BENZOIC ACID TO PREPARE A LONG-TERM ANTI-BIDICIDE
PCT/EP1991/001147 WO1993000337A1 (en) 1991-06-21 1991-06-21 (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
DK91911959T DK0589874T3 (en) 1991-06-21 1991-06-21 Use of (S) (+) -2-ethoxy-4- [N- [1- (2-piperidinophenyl) -3-methyl-1-butyl] aminocarbonylmethyl] benzoic acid to prepare
RO93-01692A RO113462B1 (en) 1991-06-21 1991-06-21 Optical isomer of 2-ethoxy-4[n-[1-(2-piperidinophenil)3-methyl-1buthyl]amin ocarbonylmethyl]-benzoic acid, process and intermediate products for preparation thereof
HK98112967.7A HK1011968B (en) 1991-06-21 Use of (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid for the preparation of a longlasting antidiabetic medicament
SK1280-93A SK281246B6 (en) 1991-06-21 1991-06-21 (S) (+) - 2-ETOXY-4- (N- (1- (2-PIPERIDINO-PHENYL) -3-METHYL-1-BUTYL) -AMINOCARBONYLMETHYL) -BENZOIC ACID, PHARMACEUTICAL COMPOSITIONS WITH ITS CONTENT HER PREPARATIONS, ITS PREPARATIONS AND ITS USE
DK99101810T DK0965591T3 (en) 1991-06-21 1991-06-21 Process for Preparation of (S) -3-Methyl-1- (2-piperidino-phenyl) -1-butylamine
AU80781/91A AU660930B2 (en) 1991-06-21 1991-06-21 (S)(+)-2-ethoxy-4-(N-(1-(2-piperidinophenyl)-3-methyl-1- butyl)aminocarbonylmethyl)benzoic acid
KR1019930703974A KR100496720B1 (en) 1991-06-21 1991-06-21 (S) (+)-2-ethoxy-4 [N- [1- (2-piperidinophenyl) -3-methyl-1-butyl] aminocarbonylmethyl] -diabetic agent containing benzoic acid
JP3511056A JP2921982B2 (en) 1991-06-21 1991-06-21 (S) (+)-2-ethoxy-4- [N- [1- (2-piperidino-phenyl) -3-methyl-1-butyl] aminocarbonylmethyl] -benzoic acid, a pharmaceutical composition containing this compound And its preparation method
PL91301997A PL170210B1 (en) 1991-06-21 1991-06-21 Method for the production of new (S) (+) - 2-ethoxy-4- (N-) 1- (2-piperidinophenyl) -3-methyl-1-butylaminocarbonylmethylbenzoic acid and its salts PL
CN91104984A CN1048722C (en) 1991-06-21 1991-07-22 (S)(+)-2-Ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbonylmethyl]-benzoic acid, pharmaceutical compositions containing compound and processes for preparation thereof
BG98300A BG61690B1 (en) 1991-06-21 1993-12-14 (S) (+) - 2-METHOXY-4- [N- [1- (2-PIPERIDINOPHENYL) -3-METHYL-1-
NO934726A NO303687B1 (en) 1991-06-21 1993-12-20 Analogous process for the preparation of the therapeutically active compound (S) (+) - 2-ethoxy-4- [N- [1- (2-piperidino-phenyl) -3-methyl-1-butyl] aminocarbonylmethyl] -benzoic acid
FI935724A FI106027B (en) 1991-06-21 1993-12-20 Process for Preparation of (S) (+) - 2-Ethoxy-4- [N- [1- (2-piperidinophenyl) -3-methyl-1-butyl] aminocarbonylmethyl] benzoic acid or its salt, and N-acetyl L-glutamine salts (s) (S) -1-2-piperidinophenyl) -3-methyl-1-butylamine and its preparation
NO1999017C NO1999017I1 (en) 1991-06-21 1999-07-20 Repaglinide
GR990402743T GR3031654T3 (en) 1991-06-21 1999-10-27 Use of (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid for the preparation of a longlasting antidiabetic medicament
UY25923A UY25923A1 (en) 1991-06-21 2000-01-17 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES MELLITUS.-

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA002111851A CA2111851C (en) 1991-06-21 1991-06-21 (s)(+)-2-ethoxy-4-[n-{1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
PCT/EP1991/001147 WO1993000337A1 (en) 1991-06-21 1991-06-21 (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
SG1996002715A SG43036A1 (en) 1991-06-21 1991-06-21 (S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid
CN91104984A CN1048722C (en) 1991-06-21 1991-07-22 (S)(+)-2-Ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbonylmethyl]-benzoic acid, pharmaceutical compositions containing compound and processes for preparation thereof

Publications (1)

Publication Number Publication Date
SG43036A1 true SG43036A1 (en) 1997-10-17

Family

ID=36781542

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996002715A SG43036A1 (en) 1991-06-21 1991-06-21 (S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid

Country Status (18)

Country Link
EP (1) EP0589874B1 (en)
JP (1) JP2921982B2 (en)
KR (1) KR100496720B1 (en)
CN (1) CN1048722C (en)
AU (1) AU660930B2 (en)
BG (1) BG61690B1 (en)
CA (1) CA2111851C (en)
DE (2) DE59109151D1 (en)
DK (2) DK0589874T3 (en)
FI (1) FI106027B (en)
GR (1) GR3031654T3 (en)
NO (2) NO303687B1 (en)
PL (1) PL170210B1 (en)
RO (1) RO113462B1 (en)
SG (1) SG43036A1 (en)
SK (1) SK281246B6 (en)
UY (1) UY25923A1 (en)
WO (1) WO1993000337A1 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA985126B (en) 1997-06-13 1998-12-14 Novo Nordisk As Novel niddm regimen
IN192862B (en) 1999-11-16 2004-05-22 Ranbaxy Lab Ltd
PE20020617A1 (en) 2000-08-22 2002-08-05 Novartis Ag COMPOSITION INCLUDING AN AT1 RECEPTOR ANTAGONIST AND AN INSULIN SECRETION POTENTIAL OR AN INSULIN SENSITIZER
EP2316469A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US20040102477A1 (en) * 2002-08-23 2004-05-27 Dr. Reddy's Laboratories Limited Polymorphic forms of (S)-Repaglinide and the processes for preparation thereof
WO2004101540A2 (en) * 2003-05-14 2004-11-25 Cilag Ag Method for the production of phenylacetic acid derivatives
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2005021524A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Process for the preparation of amorphous form of repaglinide
CN1305863C (en) * 2004-12-27 2007-03-21 浙江大学 Method for synthesizing (S)-isopropyl-(2-piperidine) phenyl-methylhistamine
GT200600381A (en) 2005-08-25 2007-03-28 ORGANIC COMPOUNDS
FR2898894B1 (en) * 2006-03-24 2008-06-06 Genfit Sa SUBSTITUTED N- (PHENETHYL) BENZAMIDE DERIVATIVE COMPOUNDS, PREPARATION AND USES
US7763607B2 (en) * 2006-04-27 2010-07-27 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
BRPI0718420A2 (en) 2006-10-20 2013-11-12 Cpd Llc RESEARCH METHOD OF INCRETIN EFFECT
US8101769B2 (en) 2007-02-15 2012-01-24 Actavis Group Ptc Ehf Process for preparing ethyl (S)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of Repaglinide
CN101772491A (en) * 2007-06-06 2010-07-07 阿克塔维什集团Ptc公司 Repaglinide substantially free of dimer impurity
EP2019097A1 (en) 2007-07-25 2009-01-28 Aurobindo Pharma Limited Process for preparing (alphaS)-alpha-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine
DK2200588T3 (en) 2007-09-25 2019-07-01 Solubest Ltd COMPOSITIONS CONCERNING LIPOFILE ACTIVE RELATIONS AND METHOD OF PRODUCTION THEREOF
DE102008046995B4 (en) * 2008-09-12 2010-08-26 Stada Arzneimittel Ag 2-ethoxy-benzoic acid
EP2177221A1 (en) 2008-10-20 2010-04-21 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of substantially optically pure Repaglinide and precursors thereof
JP5659224B2 (en) 2009-05-15 2015-01-28 ノバルティス アーゲー Arylpyridines as aldosterone synthase inhibitors
KR20120036850A (en) 2009-05-15 2012-04-18 노파르티스 아게 Benzoxazolone derivatives as aldosterone synthase inhibitors
UY32660A (en) 2009-05-28 2010-12-31 Novartis Ag AMINOBUTRIC DERIVATIVES REPLACED AS NEPRILISINE INHIBITORS
ME01923B (en) 2009-05-28 2015-05-20 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors
ES2663351T3 (en) 2009-11-17 2018-04-12 Novartis Ag Aryl-pyridine derivatives as aldosterone synthase inhibitors
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
CN102666535B (en) 2009-11-30 2015-02-25 诺华股份有限公司 Imidazole derivatives as aldosterone synthase inhibitors
EP2364977A1 (en) 2010-01-26 2011-09-14 Reuter Chemische Apparatebau KG Process for the enantiomeric enrichment of 3-methyl-1-(2-piperidinophenyl)-1-butylamine
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
CN102267959B (en) * 2011-07-06 2013-05-01 海南锦瑞制药股份有限公司 Repaglinide crystal, preparation method thereof, and solid oral preparation containing same
CN103012319B (en) * 2011-09-20 2015-06-10 浙江九洲药业股份有限公司 Repaglinide intermediate synthesis process improvement
CN102584743A (en) * 2011-12-28 2012-07-18 中国药科大学 Dimethylaminopyridine repaglinide eutectic
UY35144A (en) 2012-11-20 2014-06-30 Novartis Ag APELINE SYNTHETIC LINEAR MIMETICS FOR THE CARDIAC INSUFFICIENCY TREATMENT
LT2956464T (en) 2013-02-14 2018-07-10 Novartis Ag Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors
JP6501775B2 (en) 2013-07-25 2019-04-17 ノバルティス アーゲー Cyclic polypeptide for treatment of heart failure
AP2016009019A0 (en) 2013-07-25 2016-02-29 Novartis Ag Bioconjugates of synthetic apelin polypeptides
ES2787223T3 (en) 2014-11-07 2020-10-15 Univ Minnesota Salts and compositions useful for treating diseases
PE20171328A1 (en) 2015-01-23 2017-09-12 Novartis Ag CONJUGATES OF FATTY ACIDS AND SYNTHETIC APELLIN WITH LONGER HALF-LIFE
WO2018034627A1 (en) 2016-08-18 2018-02-22 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Pharmaceutical composition of antidiabetic tablet
UY38072A (en) 2018-02-07 2019-10-01 Novartis Ag COMPOSITIONS DERIVED FROM BUTANOIC ESTER SUBSTITUTED WITH BISPHENYL AS INHIBITORS OF NEP, COMPOSITIONS AND COMBINATIONS OF THE SAME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3347565A1 (en) * 1983-12-30 1985-07-11 Thomae Gmbh Dr K NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
BG98300A (en) 1994-09-30
DK0965591T3 (en) 2002-11-18
UY25923A1 (en) 2001-08-27
JPH06508816A (en) 1994-10-06
JP2921982B2 (en) 1999-07-19
NO303687B1 (en) 1998-08-17
SK281246B6 (en) 2001-01-18
GR3031654T3 (en) 2000-02-29
PL170210B1 (en) 1996-11-29
FI935724L (en) 1993-12-20
DE10075006I2 (en) 2004-01-08
KR100496720B1 (en) 2006-01-27
SK128093A3 (en) 1994-11-09
NO934726D0 (en) 1993-12-20
CN1068820A (en) 1993-02-10
AU8078191A (en) 1993-01-25
BG61690B1 (en) 1998-03-31
CA2111851C (en) 2002-02-26
NO934726L (en) 1993-12-20
FI935724A0 (en) 1993-12-20
EP0589874B1 (en) 1999-09-08
FI106027B (en) 2000-11-15
CN1048722C (en) 2000-01-26
RO113462B1 (en) 1998-07-30
DE10075006I1 (en) 2000-04-20
WO1993000337A1 (en) 1993-01-07
CA2111851A1 (en) 1993-01-07
AU660930B2 (en) 1995-07-13
DK0589874T3 (en) 2000-04-03
EP0589874A1 (en) 1994-04-06
DE59109151D1 (en) 1999-10-14
HK1011968A1 (en) 1999-07-23
NO1999017I1 (en) 1999-07-20

Similar Documents

Publication Publication Date Title
SG43036A1 (en) (S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid
GB2268590B (en) A tape measure device
GB2216729B (en) A compact transformer
AU116452S (en) A telephone
GB9416929D0 (en) A twin mass flyweel
GB2273527B (en) A hinge
GB9124743D0 (en) Squeeze pack
AU119763S (en) A personal computer
AU118299S (en) A personal computer unit
GB9123550D0 (en) A pack
AU118302S (en) A personal computer
NO953116D0 (en) A bale wrapping apparatus
ZA91136B (en) A horseshoe
GB9208574D0 (en) A baler
GB9200432D0 (en) An improvement for a pre-knotted necktie
GB9125041D0 (en) A hinge
GB2258628B (en) A bale accumulator
GB2294959B (en) A facing quoin
AU121056S (en) A computer
GB9300154D0 (en) A telephone
AU116023S (en) A scarf
AU118042S (en) A vice
AU113926S (en) A tie
AU114103S (en) A tie
PL53757Y1 (en) Sound signalling device for a kettle